News

News

MicroPort® EP Successfully Performs First Procedure in Belgium -

A team of electrophysiologists in Belgium have successfully completed ...

MicroPort® EP Attends the 9th All-Russian Congress of Arrhythmology -

Shanghai MicroPort® Electrophysiology MedTech Co., Ltd. (MicroPort® EP...

MicroPort® Orthopedics at the 13th Annual Congress of the Chinese Association of Orthopedic Surgeons (CAOS 2021) -

MicroPort® Orthopedics recently participated in the 13th Annual Congre...

MicroPort® Subsidiary EndoPhix® Performs World’s First Permanently Implanted Balloon Rotator Cuff Functional Reconstruction Surgery -

The first implantation of the Archimedes® Balloon Rotator Cuff Reconst...

Microport® announces the First Patients Enrolled in the European TARGET FIRST Clinical Trial of the Firehawk™ Coronary Stent -

TARGET FIRST is a prospective, multicenter, randomized, controlled cli...

MicroPort® wins Italy A' Design Award -

The Honghu joint replacement surgery robot, developed by Suzhou MicroP...

MicroPort® RIC MedTech Exhibits at CMEF 2021 -

MicroPort® RIC MedTech (Shanghai) Co., Ltd. (MicroPort® RIC) recently ...

MicroPort® EP Columbus® 3D EP Navigation System Successfully Performs First Procedure in Brazil -

The Columbus 3D EP Navigation System (Columbus®), developed by Shangha...

MicroPort® EP Receives Registration Approval from Kazakhstan Ministry of Health for Multiple Products -

Shanghai MicroPort EP MedTech Co., Ltd. (“MicroPort® EP”) has recently...

MicroPort® Launches Multiple Symposia at CIT 2021 -

Shanghai MicroPort® Medical (Group) Co., Ltd. (MicroPort®) recently at...

MicroPort® NeuroTech Numen® System and Controller Receive CE Mark -

The Numen® Coil Embolization System (Numen®) and Numen FR® Coil Detach...

Surgeries Performed by MicroPort® EP Columbus® 3D EP Navigation System Exceed 20,000 Cases Globally -

Surgeries performed by the Columbus® 3D EP Navigation System (Columbus...

MicroPort® Products Showcases at China Indigenous Brand Expo -

The China Indigenous Brand Expo was held in Shanghai Exhibition Center...

CardioFlow Medtech, Announces Four-Year Follow-Up Results of VitaFlow® Clinical Trial during CIT 2021 -

MicroPort CardioFlow Medtech Corporation (CardioFlow) recently held a ...

MicroPort® Firehawk Liberty™ Registration Approved in Belarus -

The Firehawk Liberty™ Rapamycin Target Eluting Coronary Stent System (...

FUTURE-II Trial shows MicroPort®'s Firesorb® bioresorbable scaffold is comparable in angiographic and clinical efficacy to the world’s leading coronary drug-eluting stents -

MicroPort® Scientific Corporation (MicroPort®) today have announced po...